Formativa
N. Antoni & M. Krishnan
Presentation Outline
The Problem
The Opportunity
The Environment
The Insight: Solution & How it works
The Competition
Strike the Iron while it is hot
The Leaders
Envisioning Success
Reaching Milestones
Financial Plan
Risk & Rewards
Key Issues & Conclusion
The Problem
Growing Epidemic:
20.8 million diabetics in the United States
1.5 million new cases diagnosed in 2005.
Deadly Threats:
3rd leading cause of death within the US
The Opportunity
Market Size & Growth:
$ 132 billion cost in 2002.
Healthcare
1 out of 10 dollars spent in the United States is spent on diabetes and its complications.
The Environment
Stem Cell Industry:
$14.2 billion spent on stem cell research in the next 10 years.
Stem cell therapies market expected growth $10-30 billion by 2010.
Types of Stem Cells:
Cord Blood vs. Others
The Insight
Formativa’s Technology:
Z-Cell
Sustainable Advantages:
Autoimmunity
Pluripotent
Significantly proliferate upon stimulation
Cell feeders and or growth factors are not required
Platform Technology
The Competition
Viable Future Direct Competitors:
Novocell
Via Cell
Expect severe competition from companies such as:
Eli Lilly, Novo Nordisk, J&J, Amylin, and Serono.
Existing Products and Problems:
Insulin & Dependence
Lifetime Cost of Diabetes: $233,000
Transplants
Cost of Islet transplants: $200,000 + $30,000 annually
Strike the Iron while it is hot
Stem Cell Controversy:
Moral Issues Avoided – Cord Blood
Never Found in Cord Blood Until Zhao:
New Type of ...